2. Use of totarol and pharmaceutical components containing totarol.

摘要

The invention relates to the use of drug owls to produce a preparation for the treatment of bacterial derived inflammation of the mucous membrane of the vagina, for the alleviation of adhesives in such treatment, and for the prevention and prevention of recurrence of such inflammation. The invention also includes a pharmaceutical component for the treatment of bacterial mucovaginal membrane inflammation, the reduction of the covert nature of the treatment, and the prevention and prevention of the recurrence of the inflammation, including 75 to 95 cellulose derivatives by weight, Preferably methylcelluloseIn 0.5 to 5 hydrochloric acid parties by weight, in 0.5 to 5 matrix parties by weight, the range of 1:1 to 8:1 contains phenylether content from formic acid to matrix, and in 0.001 to 5 parties by weight as active ingredient.